(MedPage Today) — The FDA expanded the indication of inebilizumab (Uplizna) to include generalized myasthenia gravis (gMG), Amgen announced Friday.
The drug is now approved to treat gMG in adults who are anti-acetylcholine receptor (AChR) or…
French group Veolia aims $1.2 billion in revenue from data centres, chips by 2030
French group Veolia aims $1.2 billion in revenue from data centres, chips by 2030 Source: www.channelnewsasia.com






